NCOA2 and polycystic ovary syndrome: Increased expression levels of SRC-2 (and SRC-3) are detected in endometrial hyperplasia as well as in the endometrium of patients diagnosed with polycystic ovary syndrome (Gregory et al., 2002), a patient group susceptible to endometrial cancer (Coulam et al., 1983; Pillay et al., 2006).